Clinical Trial Finds Marijuana Oil to be Effective in Treating Fibromyalgia

According to a brand new examine printed in the journal Pain Medicine and epublished by the National Institute of Health, the every day use of marijuana oil is efficient and well-tolerated amongst sufferers with fibromyalgia.

For the examine researchers examined the efficacy of high-THC marijuana oil versus a placebo in sufferers with fibromyalgia over an eight-week interval. On common sufferers obtained 3.6 drops per day of marijuana oil that had 4.Four mg of THC and 0.08 mg of CBD (each very low numbers).

Researchers discovered that the marijuana oil was related to “extended significant reduction” in topics’ signs, as assessed by the Fibromyalgia Impact Questionnaire (FIQ). Placebo managed sufferers obtained no such profit.

The examine states: “[T]he impact of the intervention on quality of life in the cannabis group participants was evident, resulting in reports of well-being and more energy for activities of daily living. Pain attacks were also reduced.”

The examine concludes by stating that “To our knowledge, this is the first randomized controlled trial to demonstrate the benefit of cannabis oil – a THC-rich whole plant extract – on symptoms and on [the] quality of life of people with fibromyalgia. We conclude that phytocannabinoids can be a low-cost and well-tolerated therapy for symptom relief and quality of life improvement in these patients, and we suggest that this therapy could be included as an herbal medicine option for the treatment of this condition in the Brazilian public health system.”

Interested in studying the examine’s full summary? It can be discovered under:

Objective: To decide the advantage of a tetrahydrocannabinol (THC)-rich hashish oil on signs and high quality of lifetime of fibromyalgia sufferers.

Methods: A double-blind, randomized, placebo-controlled medical trial was carried out for eight weeks to decide the advantage of a THC-rich hashish oil (24.44 mg/mL of THC and 0.51 mg/mL of cannabidiol [CBD]) on signs and high quality of lifetime of 17 ladies with fibromyalgia, residents of a neighborhood with a low socioeconomic profile and a excessive incidence of violence in the town of Florianopolis, Brazil. The preliminary dose was one drop (∼1.22 mg of THC and 0.02 mg of CBD) a day with subsequent will increase in accordance to signs. The Fibromyalgia Impact Questionnaire (FIQ) was utilized at pre- and postintervention moments and in 5 visits over eight weeks.

Results: There had been no vital variations on baseline FIQ rating between teams. However, after the intervention, the hashish group offered a big lower in FIQ rating in comparability with the placebo group (P = 0.005) and in comparability with hashish group baseline rating. (P < 0.001). Analyzing remoted gadgets on the FIQ, the hashish group offered vital enchancment on the “feel good,” “pain,” “do work,” and “fatigue” scores. The placebo group offered vital enchancment on the “depression” rating after intervention. There had been no insupportable antagonistic results.

Conclusions: Phytocannabinoids can be a low-cost and well-tolerated remedy to cut back signs and improve the standard of lifetime of sufferers with fibromyalgia. Future research are nonetheless wanted to assess long-term advantages, and research with totally different types of cannabinoids related to a washout interval should be completed to improve our data of hashish motion in this well being situation.

Source link